George Elston | Chief Financial Officer |
Nancy Lurker | President and CEO |
Dr. Jay Duker | Chief Strategic Scientific Officer |
Scott Jones | Chief Commercial Officer |
Dr. Dario Paggiarino | Senior Vice President and CMO |
I-Eh Jen | Laidlaw & Co. |
Yi Chen | H.C. Wainwright |
Andrew D’Silva | B. Riley FBR |
Dana Flanders | Guggenheim |
Good morning. My name is Josh, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Second Quarter 2020 Financial Results Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company’s request.